P1285 : Forecasting the disease burden of chronic hepatitis C in Russia
Vladimir Chulanov(Université Claude Bernard Lyon 1), I V Shestakova(Kuban State Medical University), Н. П. Блохина(Infectious Clinical Hospital No. 1), Е.А. Strebkova(Samara State Medical University), Aza Rakhmanova(City Clinical Oncology Center), О О Знойко(Moscow State University of Medicine and Dentistry), С. С. Соколов(Lomonosov Moscow State University), Olga Sagalova(Université Claude Bernard Lyon 1), E. Nurmukhametova(Infectious Clinical Hospital No. 1), A. Shevaldin(St. Petersburg State Medical Academy "City Polyclinic №44"), Homie Razavi(Center for Disease Analysis), N. Mamonova(Russian Research Center for Molecular Diagnostics and Therapy), Kathryn Razavi‐Shearer(Center for Disease Analysis), Nikolay Pimenov(Ekaterinburg Research Institute of Viral Infections), Chesnokov Ev(Tyumen State Medical University)
Cited by 6
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
Global reporting of progress towards elimination of hepatitis B and hepatitis C
|The Lancet. Gastroenterology & hepatology|2023|323